BCBruno Cauliez

Bruno Cauliez

*This is an algorithmically generated author record based on publicly available information.

Bruno Cauliez has a total of 32 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Cross-reactivity with endogenous proBNP from heart failure patients for three commercial BNP immunoassays

    by B. Cauliez, H. Santos, F. Bauer, J.P. Basuyau, A. Nadolny, G. Galpy, A. Lavoinne


  • Serum procalcitonin as a tumoral marker in small cell lung cancer.

    by M. Patout, V. Brunel, M. Salaun, S. Bota, B. Cauliez, L. Thiberville

    E17525 Background: Procalcitonin (PCT) is indicated for the early diagnosis of bacterial infections. Procalcitonin is also considered as a marker for the follow-up of thyroid carcinoma and has been found increased in patients with liver metastases. No previous study has assessed PCT in lung cancer. The aim of this study was to evaluate serum PCT as a tumoral marker for small cell lung cancer, and as a marker of liver metastasis. Methods: Sera from the Rouen University Hospital Biological Bank taken from patients that were also sampled for neurone specific enolase (NSE) were retrieved. Samples from patients with histologically proven lung cancer, taken before any treatment between December 2008 and November 2010 were selected for the study Results: From the 147 blood samples selected, 66 came from adenocarcinoma patients, 58 from neuroendocrine lung cancers (NELC) including 51 small cell lung cancers, 6 large cell lung cancers and one atypical carcinoid, 21 from squamous cell carcinomas and 2 sarcomas. Mean and median serum PCT were higher in NELC (39 ± 186 ng/ml, and 0.35 ng/ml (0.11-1.23), respectively) as compared to adecarcinoma (1.01 ± 5 and 0.08 [0.05-0.14]), or squamous cell carcinoma (0.39 ± 1.08 ng/ml and 0.1 [0.06-0.19]). From this lung cancer series, a level of 5 ng/ml PCT had a sensitivity of 18 %, and a specificity of 98 % for NELC histology. ROC under curve area for NELC was 0.764 (p < 0.001). ROC under curve area of NSE for NELC was 0.939. In lung cancer from any histology with liver metastasis, a level of 0.153 ng/ml PCT had a sensitivity of 70.4%, a specificity of 70.2% (p < 0.001), a positive and negative predictive value of 53 and 67.7%, a positive and negative likehood ratio of 2.32 and -0.002. ROC under curve area was 0.749 (p < 0.001). ROC under curve area of NSE for liver metastasis was 0.759. Conclusions: PCT as lower sensitivity and specificity than NSE for the diagnosis of NELC, and a similar increase than NSE in liver metastases. Serum PCT should not be used for the early diagnosis of bacterial infection in patients with a NELC and/or with liver metastasis.

  • Is heparin plasma suitable for the determination of B-type natriuretic peptide on the Beckman-Coulter Access 2?

    by Humberto Santos, Bruno Cauliez, Christophe Tron, Valery Brunel, Alain Lavoinne

    Background: The use of heparin as an alternative to EDTA in the production of plasma samples is of particular interest for B-type natriuretic peptide (BNP) measurements. Lithium heparin is now widely used for the determination of biochemical parameters, including cardiac markers. The goal of this study was to determine the feasibility of measuring BNP using heparin plasma instead of EDTA plasma with the Access 2 system (Beckman-Coulter). Methods: BNP was determined in heparin plasma and EDTA plasma from 24 patients within 1 h of blood collection. Additional measurements were performed with heparin plasma, every hour for the first 4 h, and then 8 h after the collection of blood that was stored at room temperature. Results: At H0, the observed BNP concentrations in heparin plasma were much higher (mean values 65% higher) than those in EDTA plasma. Using predetermined thresholds, this difference would lead to 30% discordance between samples in heparin and EDTA. BNP stability decreased over time in heparin plasma: immunoreactivity decreased approximately by 30% during the first 2 h and by 60% after 8 h. Conclusions: Heparin plasma does not seem to be a suitable alternative to EDTA plasma for measurement of BNP using the Access 2 system, even if measurements are performed immediately after blood sampling. Clin Chem Lab Med 2010;48:399–401.


    • 1 February 2007
      • Vol. 65  (1) , 93-8

    [NT-proBNP measurement on Immulite 2500 (DPC): analytical performance and comparison with Roche Diagnostics and Dade-Behring NT-proBNP immunoassays].

    by B Cauliez, S Boucher, A Duflo-Leroy, A Lavoinne

    The measurement of the N-terminal part of the proBNP (NT-proBNP) may be used to assess the secretion of the B-type natriuretic peptide (BNP), a marker of heart failure. In this study, we have evaluated the NT-proBNP immunoassay proposed by DPC Company for the Immulite 2500 analyzer and compared the results with those obtained with the two other immunoassays respectively commercialized by Roche Diagnostics (Elecsys 2010 analyzer) and Dade-Behring (Dimension RXL). The obtained results show very good general performance of the DPC's technique with a CV inferior to 8% for the values superior to 40 ng/L. The within run CVs are 3.1, 3.5 and 3.5% and the between run CVs are 3.8, 4.7 and 4.8% for the NT-proBNP levels of 151, 1601 and 5255 ng/L, respectively. We found a very good correlation between DPC's and Roche Diagnostics's assays (regression analysis: y = 0.88 x + 25.2 ; r = 0.998) and DPC's and Dade-Behring assays (regression analysis: y = 0.93 x + 16.4 ; r = 0.997). Although a small bias appeared between these assays, similar cut-points may be used to exclude both heart failure in ambulatory patients and cardiac origin in acute dyspnea.


    • 4 February 2005
      • Vol. 63  (1) , 15-25

    [Brain natriuretic peptide: physiological, biological and clinical aspects].

    by B Cauliez, M C Berthe, A Lavoinne

    Brain natriuretic peptide is one member of the natriuretic peptide family, including also ANP, CNP, DNP and urodilatin. In human, brain natriuretic peptide is mainly secreted by the cardiac ventricles. BNP is synthetized as pre-proBNP form, secondary cleaved in proBNP, itself equimolarly cleaved in BNP and NT-proBNP. The biological action of BNP is mediated by the NPR-A receptor. This peptide is eliminated from the systemic circulation by a neutral endopeptidase and by a clearance receptor (NPR-C). The BNP and NT-proBNP concentrations are measured using automated rapid immunoassay techniques. Plasma concentrations of the two peptides physiologically increase with age and are found to be higher in women than in men. The action of BNP against fluid expansion is explained by its vascular (vasodilatation), renal (diuretic and natriuretic) and cerebral activities. The measurement of these two peptides contributes to the diagnosis of heart failure. These peptides are prognostic markers both in heart failure and in acute coronary syndromes. In renal insufficiency, the interpretation of the increase in these two peptide concentrations may be difficult, particularly with the NT-proBNP which is mainly excreted by the kidneys.


    • 30 March 2004
      • Vol. 62  (1) , 41-6

    [Cardiac troponin I and CK-MB mass after cardiac surgery with cardiopulmonary bypass].

    by B Cauliez, M Redonnet, S Darras, D Blanchet, J-F Ménard, J-P Bessou, A Lavoinne

    Cardiac troponin I (cTnI) assay is used in the diagnosis of myocardial infarction after cardiac surgery. Variations in the cut-off value have been reported even with the same assay method. The aim of this work is to investigate the release profile of cTnI and CK-MB mass after cardiac surgery and to determine the cut-off value of cTnI and CK-MB mass allowing the diagnosis of perioperative myocardial infarction. In patients without postoperative cardiac complication, the cTnI peak was observed 24 hours after surgery both in coronary artery bypass grafting and in valve replacement. Moreover, the amount of cTnI released within the three hours after surgery is 2.5 fold higher in valve replacement than in coronary artery bypass grafting. The CK-MB peak was observed 3 hours after surgery in the two surgical procedures. In these patients, cTnI and CK-MB concentrations increased with the cross clamp time duration. In patients with postoperative myocardial infarction, the cTnI and CK-MB peaks were observed 24 hours after surgery. Diagnosis of perioperative myocardial infarction can be performed with a sensitivity of 100% at 24 hours with cut-off values of 32 and 7 microg/L for CK-MB and cTnI, respectively, both with Stratus (Dade Behring) and Immulite (DPC) analysers.


  • Troponine Ic et CK-MB après pontage coronarien avec ou sans CEC

    by B Cauliez, M Redonnet, S Darras, J Guignery, S Marinier, A Lavoinne

    • 27 June 2003
      • Vol. 61  (3) , 364-5

    [Cardiac troponin I cut-off: practice with the automated Immulite assay].

    by A Lavoinne, B Cauliez

    • 16 December 1998
      • Vol. 56  (6) , 711-5

    [Assay of cardiac troponin T on Elecsys 2010: comparison with cardiac troponin I].

    by B Cauliez, G Hue, A Lavoinne

    Cardiac troponin T (troponin Tc) of second generation has been measured on the Boehringer Elecsys 2010 analyzer. Cardiac specificity has been studied in patients presenting a rhabdomyolysis syndrome and the results compared with those obtained for cardiac troponin I (troponin Ic) measured on the Dade-Behring Stratus analyzer. The results clearly demonstrated that both troponin Tc and Ic showed similar cardiac specificity. Moreover, troponin Tc and troponin Ic can be indifferently used for the biological diagnostic of myocardial infarction or to asses reperfusion after percutaneous transluminal coronary angioplasty for acute myocardial infarction. In renal disease, troponin Tc was upper the reference limit (0.10 microgram/l) in 25% of the patients studied (20 patients). By contrast, troponin Ic was upper the reference limit (0.6 microgram/l) in only one patient.

    • 1 January 1996
      • Vol. 54, 359-63

    [Determination of cardiac troponin I on Stratus analyzer: prospective evaluation in unstable angina].

    by M Quillard, R Koning, H Andres, B Cauliez, G Hue, B Letac, F Matray, A Lavoinne

    Cardiac troponin I (troponin lc) has been measured on the Dade Stratus analyzer. Cardiac specificity has been studied in patients presenting a rhabdomyolysis syndrome. The obtained results clearly demonstrated that this parameter may be used as a specific marker of myocardial injury, in contrast to total creatine kinase- or mass CK-MB measurements. In unstable angina, two groups of patients may be defined: one group with elevated troponin lc (> 0.60 microgram/L; 31 patients, group I), one other with normal troponin lc (< 0.35 microgram/L; 49 patients; group II). Quantitative angiographic analysis was performed on 50 patients including 18 patients from group I. Group I showed a more severe culprit lesion than group II. All the results suggested that troponin Ic might be an indicator of severity in unstable angina.